⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BCAX News
Bicara Therapeutics Inc. Common Stock
Form 8-K
sec.gov
BCAX
Form 8-K
sec.gov
BCAX
Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated Three-Year Overall Survival and Deep Responses Driven by TGF-β Inhibition in 1L R/M HPV-Negative HNSCC
globenewswire.com
BCAX
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
BCAX
Form 8-K
sec.gov
BCAX
Bicara Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
BCAX
Bicara Therapeutics to Report First Quarter 2026 Financial Results and Business Updates on May 11, 2026, at 8:30 AM ET
globenewswire.com
BCAX
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
BCAX
Form 8-K
sec.gov
BCAX
Bicara Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
globenewswire.com
BCAX